跳至主要内容
临床试验/NCT04149249
NCT04149249已完成不适用

CONNECT: Smoking Cessation and Lung Cancer Screening

University of California, San Francisco4 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2019年8月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
99
试验地点
4
主要终点
Assessing 30-day smoking abstinence at 3 months post lung cancer screening.

研究概览

简要总结

This clinical trial studies the impact of CONNECT on biochemically confirmed smoking abstinence among diverse current smokers who are undergoing lung cancer screening.

详细描述

The study team will develop and test a novel smoking cessation intervention, CONNECT, which will start at the time an individual is receiving lung cancer screening (LCS). CONNECT will include an interactive Video Doctor which will provide participants with information tailored to their individual responses as well as proactive outreach using brief telephone calls and text messaging to follow up smokers with motivation enhancement to refer and engage patients in evidence based smoking cessation interventions (such as quitline utilization). After development and usability testing, we will conduct a small feasibility study followed by a pilot randomized controlled trial to estimate the impact of CONNECT on biochemically confirmed 30-day smoking abstinence among diverse current smokers seen at the San Francisco Veterans Affairs Medical Center and the University of California San Francisco Division of General Internal Medicine. Participants will be randomized to CONNECT or a control condition. Data will include self-report from participants obtained at baseline, 1 and 3 months, and the electronic health record. Outcomes will be biochemically confirmed 30-day smoking abstinence at 3 months post LCS and satisfaction as well as self-reported quit attempts, and use of evidence-based smoking cessation resources (quitline, pharmacotherapy or counseling). The knowledge gained will provide the pilot data necessary to apply for a larger study to test our novel intervention for promoting smoking cessation among a diverse population of high-risk smokers undergoing Lung Cancer Screening.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 55-80
  • Male or female
  • English speaking
  • Have an already scheduled low-dose computed tomography (LDCT) visit
  • Smoke at least 1 cigarette in the last 7 days
  • Have a phone that can receive text messages.

排除标准

  • Younger than 55 or older than 80
  • Does not speak English
  • Does not have a scheduled low-dose computed tomography (LDCT) visit
  • Does not smoke at least 1 cigarette in the last 7 days
  • Does not have a phone that can receive text messages.

结局指标

主要结局

Assessing 30-day smoking abstinence at 3 months post lung cancer screening.

时间窗: Up to 3 months from date of lung cancer screening appointment.

Biochemically confirmed 30-day smoking abstinence at 3 months post lung cancer screening.

Number of participants with Self-reported quit attempts

时间窗: Up to 3 months from date of lung cancer screening appointment.

Self-reported quit attempts will be measured to assess smoking behavioral changes.

Percentage of participants who used of evidence-based smoking cessation resources

时间窗: Up to 3 months from date of lung cancer screening appointment.

Use of evidence-based smoking cessation resources such as quitline, pharmacotherapy or counseling will be measured to assess smoking behavioral changes.

次要结局

  • Change in intervention component completion rates over time(Up to 18 months.)
  • Change in Participation rate over time(Up to 18 months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验